Data integrity continues to be a hot topic impacting the pharma biotech industry. In this short video, NSF’s pharma biotech expert George Toscano shares insights of NSF’s review of 150 data integrity-related enforcement actions between January 2005 and May 2017. Results highlight the top five areas where companies were struggling most. It also includes essential advice on how you and your company should implement data integrity controls and deal with concerns.

свернуть